[시장보고서]세계의 의약품 제조 장비 시장 예측(-2029년) : 최종 제품 유형별, 장비 유형별, 지역별

세계의 의약품 제조 장비 시장 예측(-2029년) : 최종 제품 유형별, 장비 유형별, 지역별

Pharmaceutical Manufacturing Equipment Market by Machine (Mixing & Blending, Milling, Spray Drying, Granulation, Extrusion, Tablet Compression, Sterilization, and Inspection), Process (Encapsulation, Formulation, Aseptic) - Global Forecast to 2029

상품코드 : 1614458 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2024년 12월

페이지 정보 : 영문 247 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,241,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,728,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,923,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,630,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 의약품 제조 장비 시장 규모는 2024년 194억 1,000만 달러에서 2029년에는 269억 4,000만 달러로 성장하며, 예측 기간 중 CAGR은 6.8%에 달할 것으로 예측됩니다.

제네릭 의약품 수요의 증가가 의약품 제조 장비 시장의 성장을 촉진하고 있습니다. 한편, 리퍼브 장비의 수요가 의약품 제조 장비 시장의 성장을 억제하고 있습니다.

조사 범위
조사 대상년	2020-2029년
기준년	2023년
예측 기간	2024-2029
검토 단위	금액(10억 달러)
부문별	최종 제품 유형별, 장비 유형별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 기타 지역

포장기 부문은 몇 가지 주요 요인으로 인해 제약 제조 장비 시장에서 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 프리필드 시린지, 1회용 바이알, 블리스 터 팩과 같은 혁신적인 약물전달 형태는 제약 산업에서 점점 더 중요해지고 있으며, 이에 따라 첨단 정교한 포장 솔루션이 요구되고 있습니다. 또한 일련번호 부여 및 변조 방지 솔루션과 같은 첨단 포장 기술의 채택은 의약품의 안전성과 추적성에 대한 엄격한 규제 요건에 대응하고 있습니다. 또한 환자 중심 의료 증가 추세에 따라 포장은 사용자의 편의성과 컴플라이언스를 향상시키는 데 중요한 역할을 하고 있습니다. 생물학적 제제, 맞춤형 의약품 및 백신의 성장 또한 고정밀 무균 포장 환경을 필요로 하므로 첨단 포장 기계에 대한 수요를 더욱 증가시키고 있습니다.

액상 부문은 소아 의약품에 대한 규제 강화로 인해 연평균 성장률(CAGR)이 증가할 것으로 예상됩니다. 미국 식품의약국(FDA)과 같은 규제기관은 어린이들이 정제나 캡슐과 같은 고형제를 삼킬 때 직면하는 문제를 해결하기 위해 연령에 맞는 액체 의약품의 필요성을 강조하고 있습니다. 이러한 노력은 소아 치료의 순응도, 안전성, 유효성을 향상시키고, 액체 제형에 대한 수요를 크게 증가시키고 있습니다. 또한 액상 의약품은 정확한 투여가 가능하므로 소아 및 기타 환자 맞춤형 투여가 필요한 경우에 이상적입니다. 소아 의료에 대한 관심이 높아짐에 따라 제약사들은 액상 제형에 대한 기술 혁신을 통해 새로운 시장 기회를 모색하고 있습니다.

이 지역은 대형 제약회사와 중소기업이 모두 지배하는 경쟁이 치열하며, 그 결과 제품 혁신과 다양화가 촉진되고 있습니다. 새로운 제조 기술을 위한 연구개발에 대한 막대한 투자가 이 지역 시장 우위를 지원하고 있습니다. 바이오의약품은 유럽 전역에 변화를 초래하는 산업적 변화를 주도하고 있습니다. 독일은 EU에서 승인된 바이오의약품 물질의 최대 생산국이 되었습니다. 이러한 성장은 바이오의약품의 매출 증가와 일치하여 유럽 의약품 제조 장비 시장을 더욱 강화하고 있습니다.

세계의 의약품 제조 장비 시장에 대해 조사했으며, 최종 제품 유형별, 장비 유형별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

서론
시장 역학
고객 비즈니스에 영향을 미치는 동향/혼란
가격 분석
밸류체인 분석
에코시스템 분석
AI/생성형 AI가 의약품 제조 장비 시장에 미치는 영향
기술 분석
특허 분석
무역 분석
2025-2026년의 주요 컨퍼런스와 이벤트
사례 연구
규제의 상황
Porter's Five Forces 분석
주요 이해관계자와 구입 기준

제6장 의약품 제조 장비 공급업체와 애프터마켓 공급업체

서론
OEM
애프터마켓 공급업체

제7장 의약품 기기의 주요 제조 공정

서론
배합 프로세스
정제화 및 인캡슐레이션 프로세스
무균 프로세스
포장 공정
품질관리 프로세스

제8장 의약품 제조 장비 최종사용자

서론
의약품 제조업체
CMO

제9장 의약품 제조 장비 시장, 최종 제품 유형별

서론
고체
액체

제10장 의약품 제조 장비 시장, 장비 유형별

서론
포장기계
충전기
스프레이 건조 장비
혼합·블렌드기
밀링 설비
압출 장비
정제 압축기
검사 장비
조립 장비
멸균 장비

제11장 의약품 제조 장비 시장, 지역별

서론
북미
- 북미의 거시경제 전망
- 미국
- 캐나다
- 멕시코
유럽
- 유럽의 거시경제 전망
- 영국
- 독일
- 프랑스
- 이탈리아
- 기타
아시아태평양
- 아시아태평양의 거시경제 전망
- 중국
- 일본
- 인도
- 한국
- 기타
기타 지역
- 기타 지역의 거시경제 전망
- 중동
- 아프리카
- 남미

제12장 경쟁 구도

개요
주요 참여 기업의 전략/강점, 2022-2024년
매출 분석, 2019-2023년
시장 점유율 분석, 2023년
기업 평가와 재무 지표, 2024년
브랜드/제품 비교
기업 평가 매트릭스 : 주요 참여 기업, 2023년
기업 평가 매트릭스 : 스타트업/중소기업, 2023년
경쟁 시나리오

제13장 기업 개요

주요 참여 기업
- GEA GROUP AKTIENGESELLSCHAFT
- I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
- SYNTEGON TECHNOLOGY GMBH
- ACG
- THERMO FISHER SCIENTIFIC INC.
- ROMACO GROUP
- KORBER AG
- MARCHESINI GROUP S.P.A.
- MG2 S.R.L.
- GLATT GMBH
기타 기업
- BAUSCH+STROBEL SE+CO. KG
- COPERION GMBH
- ELIZABETH COMPANIES
- FETTE COMPACTING
- FREUND
- KORSCH AG
- L.B. BOHLE MASCHINEN UND VERFAHREN GMBH
- LFA MACHINES
- CVC TECHNOLOGIES, INC.
- OHARA TECHNOLOGIES
- PRISM PHARMA MACHINERY
- SAINTYCO
- SILVERSON
- YENCHEN MACHINERY CO., LTD
- QUALICAPS
- COESIA S.P.A.
- UHLMANN
- AUTOMATED SYSTEMS OF TACOMA, LLC

제14장 부록

KSA

영문 목차

영문목차

The global pharmaceutical manufacturing equipment market size is projected to grow from USD 19.41 billion in 2024 to USD 26.94 billion in 2029, recording a CAGR of 6.8% during the forecast period. Rising demand for generic drugs is driving the growth of the pharmaceutical manufacturing equipment market. Whereas the demand for refurbished equipments is restraining the growth of the pharmaceutical manufacturing equipment market.

Scope of the Report
Years Considered for the Study	2020-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Billion)
Segments	By equipment type, end-product type, process, end user, supplier type, and region
Regions covered	North America, Europe, APAC, RoW

"Packaging machines segment is expected to witness highest CAGR during the forecasted period in pharmaceutical manufacturing equipment market."

The packaging machines segment is expected to have the highest CAGR in the pharmaceutical manufacturing equipment market due to a few critical factors. Innovative drug delivery formats such as pre-filled syringes, single-dose vials, and blister packs are gaining much importance in the pharmaceutical industry, which requires advanced and sophisticated packaging solutions. In addition, adoption of sophisticated packaging technologies, such as serialization and tamper-evident solutions, is stringent regulatory requirements for drug safety and traceability. It is also due to the growing trend of patient-centric healthcare, where packaging is playing an important role in enhancing user convenience and compliance. The growth in biologics, personalized medicines, and vaccines also requires highly precise and sterile packaging environments, thereby further driving demand for advanced packaging machines.

"Liquid segment is likely to witness highest CAGR in pharmaceutical manufacturing equipment market during forecasted period ."

The liquid segment is witnessing the CAGR due to regulatory emphasis on pediatric formulations. Regulatory bodies such as the US Food and Drug Administration (FDA) have stressed the need for age-appropriate liquid medications to address the challenges children face with swallowing solid forms like tablets and capsules. This push ensures better compliance, safety, and efficacy in pediatric treatments, significantly driving demand for liquid dosage forms. Additionally, liquid medications allow precise dosing, making them ideal for children and other patients requiring tailored administration. The growing focus on pediatric health has led pharmaceutical companies to innovate in liquid formulations, opening new market opportunities.

"Europe is expected to hold the second largest market share of the pharmaceutical manufacturing equipment market during forecasted period".

The region is marked by a very competitive landscape, dominated by both large pharmaceutical companies and SMEs, thus facilitating innovation and diversification in terms of products. A tremendous investment in R&D for new manufacturing technologies supports the region's dominance in this market. Biopharmaceuticals form a great shift in the industry and have transformed it across Europe; Germany has emerged to be the largest producer of EU-approved biopharmaceutical substances. This growth is matched by increasing revenues from biologics, which further strengthens the the pharmaceutical manufacturing equipment market in Europe.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

By Company Type - Tier 1 - 40%, Tier 2 - 35%, Tier 3 - 25%
By Designation- C-level Executives - 45%, Directors - 35%, Others - 20%
By Region-North America - 30%, Europe - 25%, Asia Pacific - 40%, RoW - 5%

The pharmaceutical manufacturing equipment market is dominated by a few globally established players such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India), Korber AG (Germany), Thermo Fisher Scientific Inc. (US), Marchesini Group (Italy), MG2 s.r.l (Italy), Glatt GmbH (Germany). The study includes an in-depth competitive analysis of these key players in the pharmaceutical manufacturing equipment market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the pharmaceutical manufacturing equipment and forecasts its size by equipment type, end product type, and region. The report also discusses the drivers, restraints, opportunities, and challenges pertaining to the market. It gives a detailed view of the market across four main regions-North America, Europe, Asia Pacific, and RoW. Supply chain analysis has been included in the report, along with the key players and their competitive analysis in the pharmaceutical manufacturing equipment ecosystem.

Key Benefits to Buy the Report:

Analysis of key drivers (Rising demand for pharmaceuticals, technological advancements in equipment and growing implementation & adoption of regulatory guidelines). Restraint (Demand for refurbished equipment), Opportunity (Growth in personalized medicines), Challenges (Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment).
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pharmaceutical manufacturing equipment market.
Market Development: Comprehensive information about lucrative markets - the report analyses the pharmaceutical manufacturing equipment market across varied regions
Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India) among others in the pharmaceutical manufacturing equipment market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 LIMITATIONS
1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 List of key secondary sources
  - 2.1.1.2 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 List of primary interview participants
  - 2.1.2.2 Breakdown of primaries
  - 2.1.2.3 Key data from primary sources
  - 2.1.2.4 Key industry insights
- 2.1.3 SECONDARY AND PRIMARY RESEARCH
2.2 MARKET SIZE ESTIMATION METHODOLOGY
- 2.2.1 BOTTOM-UP APPROACH
  - 2.2.1.1 Approach to arrive at market size through bottom-up analysis (demand side)
- 2.2.2 TOP-DOWN APPROACH
  - 2.2.2.1 Approach to arrive at market size through top-down analysis (supply side)
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
4.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
4.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
4.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing rate of chronic diseases
  - 5.2.1.2 Adoption of modular manufacturing setups
  - 5.2.1.3 Increasing implementation and adoption of regulatory guidelines
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Rising adoption of refurbished equipment
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Growing demand for personalized medicines
  - 5.2.3.2 Rising demand for biopharmaceuticals
- 5.2.4 CHALLENGES
  - 5.2.4.1 Adherence to multiple regulations and standards
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
- 5.4.1 INDICATIVE PRICING OF KEY PLAYERS, BY EQUIPMENT TYPE, 2023
- 5.4.2 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2019-2023
- 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION, 2019-2023
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
5.8 TECHNOLOGY ANALYSIS
- 5.8.1 KEY TECHNOLOGIES
  - 5.8.1.1 Digital twin
  - 5.8.1.2 Automation and robotics
  - 5.8.1.3 IoT
- 5.8.2 COMPLEMENTARY TECHNOLOGIES
  - 5.8.2.1 3D printing
- 5.8.3 ADJACENT TECHNOLOGIES
  - 5.8.3.1 CAD and CAM
5.9 PATENT ANALYSIS
5.10 TRADE ANALYSIS
- 5.10.1 IMPORT DATA (HS CODE 842230)
- 5.10.2 EXPORT DATA (HS CODE 842230)
5.11 KEY CONFERENCES AND EVENTS, 2025-2026
5.12 CASE STUDIES
- 5.12.1 ZAMBON COMPANY S.P.A. AND IMA ACTIVE COLLABORATED ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY
- 5.12.2 ACG HELPED INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM
- 5.12.3 SYNTEGON PROVIDED JIANGSU WITH AIM 5022S PLATFORM TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY
5.13 REGULATIONS LANDSCAPE
- 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.13.2 STANDARDS
5.14 PORTER'S FIVE FORCES ANALYSIS
- 5.14.1 BARGAINING POWER OF SUPPLIERS
- 5.14.2 BARGAINING POWER OF BUYERS
- 5.14.3 THREAT OF NEW ENTRANTS
- 5.14.4 THREAT OF SUBSTITUTES
- 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.15.2 BUYING CRITERIA

6 PHARMACEUTICAL MANUFACTURING EQUIPMENT SUPPLIERS AND AFTERMARKET SUPPLIERS

6.1 INTRODUCTION
6.2 ORIGINAL EQUIPMENT MANUFACTURERS
6.3 AFTERMARKET SUPPLIERS

7 MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES

7.1 INTRODUCTION
7.2 FORMULATION PROCESS
7.3 TABLETING AND ENCAPSULATION PROCESS
7.4 ASEPTIC PROCESS
7.5 PACKAGING PROCESS
7.6 QUALITY CONTROL PROCESS

8 END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT

8.1 INTRODUCTION
8.2 PHARMACEUTICAL MANUFACTURING COMPANIES
8.3 CONTRACT MANUFACTURING ORGANIZATIONS

9 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE

9.1 INTRODUCTION
9.2 SOLID
- 9.2.1 ONGOING TECHNOLOGICAL INNOVATIONS TO DRIVE MARKET
9.3 LIQUID
- 9.3.1 RISING APPLICATION FOR UNSTABLE DRUGS IN SOLID FORM TO BOOST DEMAND

10 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE

10.1 INTRODUCTION
10.2 PACKAGING MACHINES
- 10.2.1 RISING NEED TO ENSURE PROTECTION AGAINST DAMAGE AND CONTAMINATION TO FUEL MARKET GROWTH
10.3 FILLING MACHINES
- 10.3.1 GROWING NEED FOR COMPLIANCE WITH STRINGENT REGULATORY STANDARDS TO FOSTER MARKET GROWTH
10.4 SPRAY DRYING EQUIPMENT
- 10.4.1 PRESSING NEED TO PRODUCE HIGH-QUALITY DRUG PRODUCTS TO FUEL MARKET GROWTH
10.5 MIXING AND BLENDING MACHINES
- 10.5.1 ABILITY TO PROVIDE CONTROLLED AND CONSISTENT AGITATION AND SHEAR FORCES TO ENSURE HOMOGENEITY OF DRUG FORMULATION TO BOOST DEMAND
10.6 MILLING EQUIPMENT
- 10.6.1 RISING NEED TO REDUCE PARTICLE SIZE OF DRUG FORMULATIONS TO FOSTER MARKET GROWTH
10.7 EXTRUSION EQUIPMENT
- 10.7.1 ELEVATING USE TO PRODUCE VARIOUS DOSAGE FORMS TO FUEL MARKET GROWTH
10.8 TABLET COMPRESSION PRESSES
- 10.8.1 INCREASING PREFERENCE FOR SOLID DOSAGE FORMS TO DRIVE MARKET
10.9 INSPECTION EQUIPMENT
- 10.9.1 SURGING NEED TO ENSURE QUALITY AND INTEGRITY OF DRUG PRODUCTS TO FOSTER MARKET GROWTH
10.10 GRANULATION EQUIPMENT
- 10.10.1 ABILITY TO IMPROVE OVERALL STABILITY AND BIOAVAILABILITY OF DRUGS TO BOOST DEMAND
10.11 STERILIZATION EQUIPMENT
- 10.11.1 GROWING DEMAND FOR CONTAMINATION-FREE DRUGS AND PRODUCTS TO DRIVE MARKET

11 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
  - 11.2.2.1 Government-led initiatives to advance pharmaceutical manufacturing capacity to drive market
- 11.2.3 CANADA
  - 11.2.3.1 Rising emphasis on strengthening domestic manufacturing capabilities to foster market growth
- 11.2.4 MEXICO
  - 11.2.4.1 Increasing focus on streamlining pharmaceutical regulatory processes to fuel market growth
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 UK
  - 11.3.2.1 Rising emphasis on developing advanced manufacturing equipment to offer lucrative growth opportunities
- 11.3.3 GERMANY
  - 11.3.3.1 Escalating demand for branded and generic drugs to foster market growth
- 11.3.4 FRANCE
  - 11.3.4.1 Government-led policies to encourage investment and innovation in pharmaceutical manufacturing industry to accelerate demand
- 11.3.5 ITALY
  - 11.3.5.1 Growing focus on establishing pharmaceutical manufacturing facilities to create significant growth opportunities
- 11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 CHINA
  - 11.4.2.1 Surging FDIs and regulatory reforms to streamline drug approvals to offer lucrative growth opportunities
- 11.4.3 JAPAN
  - 11.4.3.1 Increasing demand for innovative pharmaceutical manufacturing solutions to fuel market growth
- 11.4.4 INDIA
  - 11.4.4.1 Government-led initiatives to strengthen domestic manufacturing to boost demand
- 11.4.5 SOUTH KOREA
  - 11.4.5.1 Low import tariffs and enhanced regulatory transparency to attract foreign investments to foster market growth
- 11.4.6 REST OF ASIA PACIFIC
11.5 ROW
- 11.5.1 MACROECONOMIC OUTLOOK FOR ROW
- 11.5.2 MIDDLE EAST
  - 11.5.2.1 Expanding pharmaceutical manufacturing infrastructure to offer growth opportunities
  - 11.5.2.2 GCC
  - 11.5.2.3 Rest of Middle East
- 11.5.3 AFRICA
  - 11.5.3.1 Rising investment in local pharmaceutical manufacturing to fuel market growth
- 11.5.4 SOUTH AMERICA
  - 11.5.4.1 Introduction of tax incentives to strengthen pharmaceutical manufacturing to support market growth

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2024
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024
12.6 BRAND/PRODUCT COMPARISON
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.7.1 STARS
- 12.7.2 EMERGING LEADERS
- 12.7.3 PERVASIVE PLAYERS
- 12.7.4 PARTICIPANTS
- 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 12.7.5.1 Company footprint
  - 12.7.5.2 Region footprint
  - 12.7.5.3 Primary packaging equipment footprint
  - 12.7.5.4 Secondary packaging equipment footprint
  - 12.7.5.5 Type footprint
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.8.1 PROGRESSIVE COMPANIES
- 12.8.2 RESPONSIVE COMPANIES
- 12.8.3 DYNAMIC COMPANIES
- 12.8.4 STARTING BLOCKS
- 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 12.8.5.1 Detailed list of key startups/SMEs
  - 12.8.5.2 Competitive benchmarking of key startups/SMEs
12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES
- 12.9.2 DEALS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 GEA GROUP AKTIENGESELLSCHAFT
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products/Solutions/Services offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Product launches
    - 13.1.1.3.2 Deals
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Key strengths/Right to win
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses/Competitive threats
- 13.1.2 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products/Solutions/Services offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Deals
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Key strengths/Right to win
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses/Competitive threats
- 13.1.3 SYNTEGON TECHNOLOGY GMBH
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products/Solutions/Services offered
  - 13.1.3.3 Recent developments
    - 13.1.3.3.1 Product launches
    - 13.1.3.3.2 Deals
    - 13.1.3.3.3 Expansions
  - 13.1.3.4 MnM view
    - 13.1.3.4.1 Key strengths/Right to win
    - 13.1.3.4.2 Strategic choices
    - 13.1.3.4.3 Weaknesses/Competitive threats
- 13.1.4 ACG
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products/Solutions/Services offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Deals
    - 13.1.4.3.2 Expansions
  - 13.1.4.4 MnM view
    - 13.1.4.4.1 Key strengths/Right to win
    - 13.1.4.4.2 Strategic choices
    - 13.1.4.4.3 Weaknesses/Competitive threats
- 13.1.5 THERMO FISHER SCIENTIFIC INC.
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products/Solutions/Services offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Deals
    - 13.1.5.3.2 Expansions
  - 13.1.5.4 MnM view
    - 13.1.5.4.1 Key strengths/Right to win
    - 13.1.5.4.2 Strategic choices
    - 13.1.5.4.3 Weaknesses/Competitive threats
- 13.1.6 ROMACO GROUP
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products/Solutions/Services offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Product launches
    - 13.1.6.3.2 Deals
- 13.1.7 KORBER AG
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products/Solutions/Services offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Deals
    - 13.1.7.3.2 Expansions
- 13.1.8 MARCHESINI GROUP S.P.A.
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products/Solutions/Services offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Product launches
    - 13.1.8.3.2 Deals
- 13.1.9 MG2 S.R.L.
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products/Solutions/Services offered
  - 13.1.9.3 Recent developments
    - 13.1.9.3.1 Product launches
- 13.1.10 GLATT GMBH
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products/Solutions/Services offered
13.2 OTHER PLAYERS
- 13.2.1 BAUSCH+STROBEL SE + CO. KG
- 13.2.2 COPERION GMBH
- 13.2.3 ELIZABETH COMPANIES
- 13.2.4 FETTE COMPACTING
- 13.2.5 FREUND
- 13.2.6 KORSCH AG
- 13.2.7 L.B. BOHLE MASCHINEN UND VERFAHREN GMBH
- 13.2.8 LFA MACHINES
- 13.2.9 CVC TECHNOLOGIES, INC.
- 13.2.10 OHARA TECHNOLOGIES
- 13.2.11 PRISM PHARMA MACHINERY
- 13.2.12 SAINTYCO
- 13.2.13 SILVERSON
- 13.2.14 YENCHEN MACHINERY CO., LTD
- 13.2.15 QUALICAPS
- 13.2.16 COESIA S.P.A.
- 13.2.17 UHLMANN
- 13.2.18 AUTOMATED SYSTEMS OF TACOMA, LLC

14 APPENDIX

14.1 INSIGHTS FROM INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.4 CUSTOMIZATION OPTIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS